Publication: Magyar Közlöny
Issue: MK-2007-56 (Year: 2007, Number: 56)
Era: 2004-2010
Section: 
Paragraph Index: 72

5. Corticotrophins. Unless the Athlete can demonstrate that the concentration was due to a physiological or pathological condition, a Sample will be deemed to contain a Prohibited Substance (as listed above) where the concentration of the Prohibited Substance or its metabolites and/or relevant ratios or markers in the Athlete’s Sample so exceeds the range of values normally found in humans that it is unlikely to be consistent with normal endogenous production. The presence of other substances with a similar chemical structure or similar biological effect(s), diagnostic marker(s) or releasing factors of a hormone listed above or of any other finding which indicate(s) that the substance detected is of exogenous origin, will be reported as an Adverse Analytical Finding. S3. BETA-2 AGONISTS All beta-2 agonists including their D- and L-isomers are prohibited. Their use requires a Therapeutic Use Exemption. As an ex cep ti on, for mo te rol, sal bu ta mol, sal me te rol and ter bu ta li ne, when ad mi nis te red by in ha la ti on to pre vent and/or tre at asth ma and exer ci se-in du ced asth ma/ broncho-constriction re qu i re an abb re vi a ted The ra pe u tic Use Exemp ti on. Despite the granting of a Therapeutic Use Exemption, when the Laboratory has reported a concentration of salbutamol (free plus glucuronide) greater than 1000 ng/mL, this will be considered to be an Adverse Analytical Finding unless the athlete proves that the abnormal result was the consequence of the therapeutic use of inhaled salbutamol. S4. AGENTS WITH ANTI-ESTROGENIC ACTIVITY The following classes of anti-estrogenic substances are prohibited.

Source: https://magyarkozlony.hu/hivatalos-lapok/46f6c6a1ded80d2e43f529a4cf8ff72403f2abf4/dokumentumok/32e8875d26273f922b8b5ce8d3049e0929b015a8/letoltes